P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent

Molecular Medicine Reports

Volumn 7, Issue 1, 2013, Pages 115-121

  Xu, Dong ^a,b   Tian, Wei ^a,b   Shen, Hong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Acquired drug resistance; Curcumin; Curcuminoids; P glycoprotein

Indexed keywords

CURCUMIN; CURCUMINOID; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL STRAIN K 562; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CURCUMIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; K562 CELLS; NF-KAPPA B; P-GLYCOPROTEIN;

EID: 84873817243     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1106     Document Type: Article

References (28)

1. Cole SP, Bhardwaj G, Gerlach JH, et al: Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650-1654, 1992.
2. Gottesman MM, Fojo T and Bates SE: Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2: 48-58, 2002.
3. Schinkel AH and Jonker JW: Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55: 3-29, 2003.
4. Xu D, Lu Q and Hu X: Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243: 274-280, 2006.
5. Pan Q, Lu Q, Zhang K and Hu X: Dibenzocyclooctadiene lingnans: a class of novel inhibitors of P-glycoprotein. Cancer Chemother Pharmacol 58: 99-106, 2006.
6. Sun M, Xu X, Lu Q, Pan Q and Hu X: Schisandrin B: a dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1. Cancer Lett 246: 300-307, 2007.
7. Sakaeda T, Nakamura T, Hirai M, et al: MDR1 up-regulated by apoptotic stimuli suppresses apoptotic signaling. Pharm Res 19: 1323-1329, 2002.
8. Gottesman MM and Ling V: The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580: 998-1009, 2006.
9. Xu D TW and Shen H: Curcumin prevents induced drug resistance: a novel function? Chin J Cancer Res 23: 218-223, 2011.
10. Schiedlmeier B, Kuhlcke K, Eckert HG, Baum C, Zeller WJ and Fruehauf S: Quantitative assessment of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cells engrafted in nonobese diabetic/severe combined immunodeficient mice. Blood 95: 1237-1248, 2000.
11. Cocker HA, Tiffin N, Pritchard-Jones K, Pinkerton CR and Kelland LR: In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line. Clin Cancer Res 7: 3193-3198, 2001.
12. Shen H, Xu W, Chen Q, Wu Z, Tang H and Wang F: Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcription. J Cancer Res Clin Oncol 136: 659-665, 2010.
13. Yague E, Armesilla AL, Harrison G, et al: P-glycoprotein (MDR1) expression in leukemic cells is regulated at two distinct steps, mRNA stabilization and translational initiation. J Biol Chem 278: 10344-10352, 2003.
14. Hu XF, Slater A, Wall DM, Parkin JD, Kantharidis P and Zalcberg JR: Cyclosporin A and PSC 833 prevent up-regulation of MDR1 expression by anthracyclines in a human multidrug-resistant cell line. Clin Cancer Res 2: 713-720, 1996.
15. 2+ and the activation of caspase-3. Anticancer Res 26: 4379-4389, 2006.
16. Lin YG, Kunnumakkara AB, Nair A, et al: Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res13: 3423-3430, 2007.
17. Yodkeeree S, Chaiwangyen W, Garbisa S and Limtrakul P: Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 20: 87-95, 2009.
18. Tamvakopoulos C, Dimas K, Sofianos ZD, et al: Metabolism and anticancer activity of the curcumin analogue, dimethoxycurcumin. Clin Cancer Res 13: 1269-1277, 2007.
19. Anuchapreeda S, Leechanachai P, Smith MM, Ambudkar SV and Limtrakul PN: Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64: 573-582, 2002.
20. Limtrakul P, Anuchapreeda S and Buddhasukh D: Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4: 13, 2004.
21. Chearwae W, Wu CP, Chu HY, Lee TR, Ambudkar SV and Limtrakul P: Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol 57: 376-388, 2006.
22. Li Y, Revalde JL, Reid G and Paxton JW: Modulatory effects of curcumin on multi-drug resistance-associated protein 5 in pancreatic cancer cells. Cancer Chemother Pharmacol 68: 603-610, 2011.
23. Egashira M, Kawamata N, Sugimoto K, Kaneko T and Oshimi K: P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833. Blood 93: 599-606, 1999.
24. Su CC, Chen GW, Lin JG, Wu LT and Chung JG: Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26: 1281-1288, 2006.
25. Amiri KI and Richmond A: Role of nuclear factor-kappa B in melanoma. Cancer Metastasis Rev 24: 301-313, 2005.
26. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J and Aggarwal BB: Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67: 3853-3861, 2007.
27. Ahsan H, Parveen N, Khan NU and Hadi SM: Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact 121: 161-175, 1999.
28. Sandur SK, Pandey MK, Sung B, et al: Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis 28: 1765-1773, 2007.